The filing for a stock shelf offering of 7.9 million shares by Mirum Pharmaceuticals could lead to dilution of the value of existing shares. This is because the increase in the number of shares available in the market could exceed the demand, leading to a decrease in the price per share. Therefore, this news could potentially have a negative impact on the short-term stock price of MIRM.